{"product_id":"oncology-molecular-diagnostics-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Oncology Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eOncology Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nThe global oncology molecular diagnostics market size reached US$ 3.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2028, exhibiting a growth rate (CAGR) of 14.9% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eOncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell proteins. Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer. These diagnostics solutions find application in clinical and point-of-care (POC) testing for early detection of cancer. They are also used in blood banks to identify pathogens and infectious diseases present in the donated blood samples.\u003c\/p\u003e\n\n\u003cp\u003eThe rising prevalence of cancer on account of changing lifestyles, growing geriatric population, and the increasing trend of smoking represents one of the major factors impelling the global oncology molecular diagnostics market growth. Apart from this, the escalating demand for rapid and accurate diagnosis, along with advancements in next generation sequencing (NGS) techniques, is contributing to the growth of the market. Furthermore, a rise in the number of individuals suffering from viral and bacterial infections and the increasing participation in blood donation campaigns is positively influencing the demand for oncology molecular diagnostics worldwide. However, due to the sudden outbreak of the coronavirus disease (COVID-19), several healthcare institutions are undertaking steps to mitigate the risk of the pandemic on cancer patients by reducing the number of medical appointments. Moreover, regular screening for cancer patients has witnessed a decline due to the repurposing of diagnostics resources for providing COVID-19 testing and consequent reduction in oncology testing.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each sub-segment of the global oncology molecular diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on cancer type, product, technology and end-user.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Cancer Type:\u003c\/p\u003e\n\n\u003cp\u003eBreast Cancer\u003cbr\u003e\nProstate Cancer\u003cbr\u003e\nColorectal Cancer\u003cbr\u003e\nCervical Cancer\u003cbr\u003e\nLiver Cancer\u003cbr\u003e\nLung Cancer\u003cbr\u003e\nBlood Cancer\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Product:\u003c\/p\u003e\n\n\u003cp\u003eInstruments\u003cbr\u003e\nReagents\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Technology:\u003c\/p\u003e\n\n\u003cp\u003ePolymerase Chain Reaction (PCR)\u003cbr\u003e\nIn Situ Hybridization\u003cbr\u003e\nChips and Microarrays\u003cbr\u003e\nIsothermal Nucleic Acid Amplification Technology (INAAT)\u003cbr\u003e\nMass Spectrometry\u003cbr\u003e\nDNA and NGS Sequencing\u003cbr\u003e\nTranscription Mediated Amplification (TMA)\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by End-User:\u003c\/p\u003e\n\n\u003cp\u003eHospitals and Clinics\u003cbr\u003e\nReference Laboratories\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nIndonesia\u003cbr\u003e\nOthers\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUnited Kingdom\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRussia\u003cbr\u003e\nOthers\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nOthers\u003cbr\u003e\nMiddle East and Africa\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Landscape:\u003cbr\u003e\nThe report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Inc., Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic, Inc., Qiagen N.V., Siemens Healthcare and Sysmex Corporation.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003c\/p\u003e\n\n\u003cp\u003eHow has the global oncology molecular diagnostics market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global oncology molecular diagnostics market?\u003cbr\u003e\nWhat are the key regional markets?\u003cbr\u003e\nWhat is the breakup of the market based on the cancer type?\u003cbr\u003e\nWhat is the breakup of the market based on the product?\u003cbr\u003e\nWhat is the breakup of the market based on the technology?\u003cbr\u003e\nWhat is the breakup of the market based on the end-user?\u003cbr\u003e\nWhat are the various stages in the value chain of the industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the industry?\u003cbr\u003e\nWhat is the structure of the global oncology molecular diagnostics market and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"June, 2023 \/ 139 Pages \/ MCW16237122","offer_id":47652371300658,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/oncology-molecular-diagnostics-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}